Healthline: What we know about breakthrough monkeypox cases
UC expert says people with certain medical conditions may be less likely to be protected
The World Health Organization announced recently that breakthrough infections have been reported in people who had been vaccinated against monkeypox. Healthline reported there is limited data available on the efficacy of the JYNNEOS shot, so it will take time to understand how effective it is at preventing infection. Data from the 1980s has shown that the vaccine was at least 85% effective, however, some health experts expect that number to change in the current outbreak. One of the experts cited in the Healthline story was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Marketing + Brand
Fichtenbaum says that the vaccine has not been tested in humans to a large extent, so 85% is really a ballpark estimate.
Healthline reported the strength of people’s immune systems varies and certain individuals may not mount a strong enough immune response to avoid getting sick even if they are fully immunized.
“As always, those with immunosuppression, cancer, transplant patients, and persons with HIV who have a lower CD4+ lymphocyte count below 350 cells/mm3 would be more likely to not respond as well to vaccine and have a breakthrough infection,” Fichtenbaum said.
People older than 60 are also likely to be less protected, Fichtenbaum added.
Fichtenbaum says we are still learning about how common breakthrough infections are, and we don’t have the best track record for preventing the spread of infectious diseases during public health emergencies.
“Time will tell how many breakthroughs occur,” Fichtenbaum said.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Photos: UC celebrates 2026 commencement
May 4, 2026
The Cincinnati Enquirer shares a photo gallery from UC's spring commencement at Nippert Stadium.
UC team first in world to achieve complete remission of aggressive pituitary tumor through immunotherapy
May 4, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center were the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The case of the complete remission, which had been previously published in the Neurosurgery Journal, was verified as the first in the world with a novel immunotherapy regimen detailed in a new publication in the journal Surgical Neurology International.
Why is it so difficult to own a restaurant in Cincinnati?
May 1, 2026
WLWT turned to UC Lindner College of Business economics professor David Brasington for a look into the factors that make restaurant ownership so difficult in today's market.